Efficacy and Safety Study of Herbal Supplements (SR-L-01, SR-B-01 and SI-S-01) in the Management of Prediabetes and Mild to Moderate Hyperlipidemia

Fecha de inicio: 1 de abril de 2012

Inclusion Criteria: As per ATP III guidelines: Baseline LDL ranging 160-189 mg/dL, TC >200 mg/dL and with no or one of the below risk factors Current cigarette smoking Family history of premature Coronary Heart Disease(CHD); in male first degree relative <55 years; in female first degree relative <65 years) Hypertension (BP >140/90 mmHg or on antihypertensive medication) Low HDL-C (<40 mg/dL) Age (men > 40 years) Impaired glucose tolerance (2-hour post 75 g OGTT glucose levels in the range of ≥140 to ≤ 200 mg/dL) Impaired fasting sugar (Fasting blood sugar levels in the range of ≥ 100 to ≤125 mg/dL) Being mentally competent and able to understand all study requirements and sign the informed consent form. Exclusion Criteria: Patients with severe liver, renal, cardiac or brain diseases. Pregnant or lactating women or women of child bearing potential whom are not practicing a reliable form of birth control (either with IUD or with stable usage of oral contraceptives). Unable to complete follow up. Subjects on any medication that would affect evaluation like Statins.